E-LIB Suche - Ergebnisse für: Cunningham, A.

1

483P Germinal centre microarchitecture in tumour-negative l..:

Kloft, M. ; Budginaite, E. ; Magee, D.R....
Annals of Oncology. 35 (2024) - p. S192 , 2024

Link: https://doi.org/10.1016/..

2

Development of the What Matters 2 Adults (WM2A) wellbeing m..:

Howard, K. ; Garvey, G. ; Anderson, K....
Social Science & Medicine. 347 (2024) - p. 116694 , 2024

Link: https://doi.org/10.1016/..

3

A prospective re-audit on insulin prescribing and administr..:

Hogan-Murphy, D ; Cunningham, D ; Ero, A...
International Journal of Pharmacy Practice. 32 (2024) Supplement_1 - p. i30-i31 , 2024

Link: https://doi.org/10.1093/..

4

Phase II trial of domatinostat (4SC-202) in combination wit..:

Cartwright, E. ; Slater, S. ; Saffery, C....
ESMO Open. 9 (2024) 4 - p. 102971 , 2024

Link: https://doi.org/10.1016/..

5

EPS5.09 Optimising vitamin D status in cystic fibrosis pati..:

Kettley, C. ; Cunningham, J. ; Bradshaw, C....
Journal of Cystic Fibrosis. 23 (2024) - p. S49 , 2024

Link: https://doi.org/10.1016/..

6

32P Patient-reported tolerability of sotorasib (soto) and p..:

Taieb, J. ; Fakih, M. ; Salvatore, L....
Annals of Oncology. 35 (2024) - p. S16-S17 , 2024

Link: https://doi.org/10.1016/..

7

P324 Changes to the dietetic landscape in a UK adult cystic..:

Bradshaw, C. ; Cunningham, J. ; Kettley, C....
Journal of Cystic Fibrosis. 23 (2024) - p. S168 , 2024

Link: https://doi.org/10.1016/..

8

Maintenance durvalumab after first-line chemotherapy in pat..:

Fong, C. ; Patel, B. ; Peckitt, C....
ESMO Open. 9 (2024) 7 - p. 103622 , 2024

Link: https://doi.org/10.1016/..

9

124P Acquired resistance to first-line chemo- and EGFRab-th..:

Lane, R. ; Mencel, J. ; Turkes, F....
Annals of Oncology. 35 (2024) - p. S58 , 2024

Link: https://doi.org/10.1016/..

10

512P Predictive biomarkers and protein specific mismatch re..:

Le, H.M.L. ; Paiva, R.V.D.S. ; Farag, S....
Annals of Oncology. 35 (2024) - p. S204 , 2024

Link: https://doi.org/10.1016/..

11

Tislelizumab versus chemotherapy as second-line treatment f..:

Ajani, J. ; El Hajbi, F. ; Cunningham, D....
ESMO Open. 9 (2024) 1 - p. 102202 , 2024

Link: https://doi.org/10.1016/..

12

30P Immunological markers of pathological and clinical and ..:

Challoner, B.R. ; Slater, S.C. ; Sansano, H.B....
Annals of Oncology. 35 (2024) - p. S15 , 2024

Link: https://doi.org/10.1016/..

13

472 Comparative genomics analysis of skin commensal Cutibac..:

Rengarajan, S. ; Zhang, A. ; Cunningham, L....
Journal of Investigative Dermatology. 144 (2024) 8 - p. S82 , 2024

Link: https://doi.org/10.1016/..

14

28P A mixed methods longitudinal process evaluation and imp..:

Hainsworth, E. ; Stapleton, S. ; Ogara, G....
Annals of Oncology. 35 (2024) - p. S14 , 2024

Link: https://doi.org/10.1016/..

15

A first report of Pseudosuccinea columella (Say, 1817), an ..:

Jones, S. ; Juhász, A. ; Makaula, P....
Parasites & Vectors. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..